CalciMedica
CALC
12 hedge funds and large institutions have $1.56M invested in CalciMedica in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.31% less ownership
Funds ownership: 2.4% → 2.09% (-0.31%)
43% less capital invested
Capital invested by funds: $2.72M → $1.56M (-$1.16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$553K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.39K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$100 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$1.07M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.61K |
| 3 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$285 |
| 4 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$52 |
CALC Hedge Fund Activity: Q3 2023 in Review
12 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2023, worth a combined $1.56M — down 43% from $2.72M a quarter earlier.
Fund positioning in CALC was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $553K. The largest seller was Deerfield Management, exiting entirely with an estimated $1.07M sold.
- 12 institutional investors held CalciMedica (CALC) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $1.56M of CalciMedica stock for Q3 2023, down 43% quarter-over-quarter.
- 3 funds opened new CalciMedica positions in Q3 2023 and 3 closed out, a net change of 0 holders.
- The largest CalciMedica buyer in Q3 2023 was Hudson Bay Capital Management, an estimated $553K added.
- The largest CalciMedica seller in Q3 2023 was Deerfield Management, an estimated $1.07M sold.
Based on aggregated 13F filings for Q3 2023.